AMBBY (Ambu AS) Total Equity: $943.7 Mil (As of Mar. 2026)


AMBBY Ambu AS AMBBY
84 GF Score
Price $9.38
GF Value $19.84
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Total Equity?

Ambu AS AMBBY -0.53% 84 Total Equity is $943.7 Mil as of Mar. 2026. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.84 (Significantly Undervalued).

Ambu AS's total equity for the quarter that ended in Mar. 2026 was $943.7 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Ambu AS Total Equity Historical Data

* Premium members only.

The historical data trend for Ambu AS's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Total Equity Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 625.26 566.85 771.79 832.69 949.05

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 857.19 912.96 949.05 946.32 943.65
AMBBY
84GF Score
Ambu AS AMBBY
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Ambu AS's Total Equity for the fiscal year that ended in Sep. 2025 is calculated as

Total Equity=Total Assets(Q: Sep. 2025 )-Total Liabilities(Q: Sep. 2025 )
=1206.951-257.902
=949.0

Ambu AS's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1176.434-232.781
=943.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $943.7 Mil mean?
Ambu AS (AMBBY) has a Total Equity of $943.7 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Ambu AS and its competitors.
Is Ambu AS's Total Equity too high?
Ambu AS's current Total Equity is $943.7 Mil. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Total Equity compare to ABT and SYK?
Ambu AS's Total Equity of $943.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Ambu AS and its competitors. Ambu AS's current Total Equity is $943.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.84, compared to a current price of $9.38 — trading 52.7% below its estimated fair value. The current Total Equity is $943.7 Mil. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Ambu AS (AMBBY), the current Total Equity is $943.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (AMBBY) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of $9.38 is trading 52.7% below its estimated GF Value™ of $19.84. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for AMBBY:

  • Total Equity: $943.7 Mil
  • GF Value™: $19.84 vs. price of $9.38 (52.7% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score

Get the complete analysis for AMBBY

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.38
Price
$19.84
GF Value